After the recent joint publications of the Backbone Domain - MSSA and PSSA Silo manuscripts in The New England Journal of Medicine (NEJM) and The Lancet, respectively, we are pleased to share some of the media coverage of these results, identifying optimal antibiotics for golden staph bloodstream infectoins:
Australia: The Age, SMH, Brisbane Times, WA Today (online), AusDoc, Newy, HMRI, RMH, Sensible Medicine, University of Newcastle
New Zealand: New Zealand Doctor, ForeignAffairs Asia Pacific News Briefing
South Africa: University of the Witwatersrand, Weekend Argus Saturday (print), Independent Online
Canada: McGill University Health Centre, La Presse (this is part of many syndicates which republished the article)
Germany: University Medical Center Magdeburg, MFA Heute, mdr
The Netherlands: ecraid, UMC Utrecht
Sweden: Lund Universitet
China: Australia Chinese Daily
Japan: Ameblo
The study results from the antibiotic backbone domain have now been published in scientific journals!
The SNAP trial includes all age groups because people of all ages.
A summary of how Staphylococcus aureus and penicillin have been instrumental in both the success and failure of one another since they met. Carly Botheras (PhD Candidate, Geelong Centre for Emerging Infectious Diseases, Barwon Health)
